These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 21524892)
21. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
22. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929 [TBL] [Abstract][Full Text] [Related]
23. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. Martins S; Tho I; Souto E; Ferreira D; Brandl M Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538 [TBL] [Abstract][Full Text] [Related]
24. Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol. Ghouchi-Eskandar N; Simovic S; Prestidge CA Int J Pharm; 2012 Feb; 423(2):384-91. PubMed ID: 22210001 [TBL] [Abstract][Full Text] [Related]
25. Interactions of hydrophilic silica nanoparticles and classical surfactants at non-polar oil-water interface. Eskandar NG; Simovic S; Prestidge CA J Colloid Interface Sci; 2011 Jun; 358(1):217-25. PubMed ID: 21450304 [TBL] [Abstract][Full Text] [Related]
26. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Huang ZR; Hua SC; Yang YL; Fang JY Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178 [TBL] [Abstract][Full Text] [Related]
27. O/W emulsions stabilised by both low molecular weight surfactants and colloidal particles: The effect of surfactant type and concentration. Pichot R; Spyropoulos F; Norton IT J Colloid Interface Sci; 2010 Dec; 352(1):128-35. PubMed ID: 20817195 [TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496 [TBL] [Abstract][Full Text] [Related]
31. Solid lipid nanoparticles and nanoemulsions containing ceramides: preparation and physicochemical characterization. Deli G; Hatziantoniou S; Nikas Y; Demetzos C J Liposome Res; 2009; 19(3):180-8. PubMed ID: 19552579 [TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil. Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575 [TBL] [Abstract][Full Text] [Related]
33. Magnetic Pickering emulsions stabilized by Fe3O4 nanoparticles. Zhou J; Qiao X; Binks BP; Sun K; Bai M; Li Y; Liu Y Langmuir; 2011 Apr; 27(7):3308-16. PubMed ID: 21344923 [TBL] [Abstract][Full Text] [Related]
34. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification. Rosenblatt KM; Bunjes H Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318 [TBL] [Abstract][Full Text] [Related]
35. Influence of particle size on lipid digestion and β-carotene bioaccessibility in emulsions and nanoemulsions. Salvia-Trujillo L; Qian C; Martín-Belloso O; McClements DJ Food Chem; 2013 Nov; 141(2):1472-80. PubMed ID: 23790941 [TBL] [Abstract][Full Text] [Related]
36. Formation and stability of nanoparticle-stabilised oil-in-water emulsions in a microfluidic chip. Priest C; Reid MD; Whitby CP J Colloid Interface Sci; 2011 Nov; 363(1):301-6. PubMed ID: 21840529 [TBL] [Abstract][Full Text] [Related]
37. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Saupe A; Gordon KC; Rades T Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354 [TBL] [Abstract][Full Text] [Related]
38. Stability of lipid excipients in solid lipid nanoparticles. Radomska-Soukharev A Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589 [TBL] [Abstract][Full Text] [Related]
39. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Attama AA; Müller-Goymann CC Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752 [TBL] [Abstract][Full Text] [Related]
40. An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives. Hung LC; Basri M; Tejo BA; Ismail R; Nang HL; Abu Hassan H; May CY Colloids Surf B Biointerfaces; 2011 Oct; 87(1):180-6. PubMed ID: 21652183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]